Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.1
38.77%
60%
—
-88.69%
20%
—
5 Years
Score4.1
Net Growth38.77%
Net Trend60%
Net Income Consistency—
Rev Growth-88.69%
Rev Trend20%
Revenue Consistency—
Fate Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 31M to $ 6M and net income went from -$ 173M to -$ 136M. Revenue increased in 1 of those 5 years; net income in 3.
Across Fate Therapeutics Inc's full reported history, from 2013 to 2025, revenue grew from $ 971K to $ 6M and net income went from -$ 20M to -$ 136M. Revenue increased in 54% of the years measured; net income in 23%.
Fate Therapeutics Inc currently holds a 5-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.72 | — |
1 Year2025-08-12 | $ 0.94 | 190.51% |
5 Years2021-08-12 | $ 90.06 | -96.98% |
10 Years2016-08-12 | $ 2.56 | 6.25% |
All Time2013-10-01 | $ 6.62 | -58.91% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2013-10-01 |
|---|---|---|---|---|---|
| Price | $ 2.72 | $ 0.94 | $ 90.06 | $ 2.56 | $ 6.62 |
| Return | — | 190.51% | -96.98% | 6.25% | -58.91% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 6M | -$ 129M | $ 174M |
| 2025 | $ 6M | -$ 136M | $ 203M |
| 2024 | $ 13M | -$ 186M | $ 279M |
| 2023 | $ 63M | -$ 160M | $ 315M |
| 2022 | $ 96M | -$ 255M | $ 436M |
| 2021 | $ 55M | -$ 212M | $ 615M |
| 2020 | $ 31M | -$ 173M | $ 482M |
| 2019 | $ 10M | -$ 98M | $ 221M |
| 2018 | $ 4M | -$ 66M | $ 201M |
| 2017 | $ 4M | -$ 42M | $ 100M |
| 2016 | $ 4M | -$ 33M | $ 92M |
| 2015 | $ 2M | -$ 29M | $ 64M |
| 2014 | $ 0.00 | -$ 25M | $ 49M |
| IPO2013 | $ 971K | -$ 20M | $ 54M |
Explore beyond FATE
You're looking at Fate Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
